Earnings Per Share (Tables)

9 Months Ended

Sep. 30, 2021

The following table presents the computation of earnings per share for the three and nine months ended September 30, 2021 and 2020:


	For the three months ended September 30,				For the nine months ended September 30,
(in millions, except share/per share amounts)	2021		2020		2021		2020
Net loss	$	(1,857)	$	(593)	$	(2,386)	$	(3,020)

Number of common shares:
Weighted average outstanding	787,032,414		571,872,413		713,455,662		551,162,559
Issued upon assumed exercise of outstanding stock options	—		—		—		—
Effect of issuance of non-vested restricted common stock	—		—		—		—
Effect of issuance of non-vested restricted units	—		—		—		—
Effect of issuance of non-vested performance units	—		—		—		—
Weighted average and potential dilutive outstanding	787,032,414		571,872,413		713,455,662		551,162,559

Loss per common share
Basic	$	(2.36)	$	(1.04)	$	(3.34)	$	(5.48)
Diluted	$	(2.36)	$	(1.04)	$	(3.34)	$	(5.48)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following table presents the common stock shares equivalent excluded from the calculation of diluted earnings per share for the three and nine months ended September 30, 2021 and 2020, as they would have had an antidilutive effect:


	For the three months ended September 30,		For the nine months ended September 30,
	2021	2020	2021	2020
Unexercised stock options	3,699,448	4,425,886	3,742,486	4,519,385
Unvested share-based payment	762,945	939,941	827,279	946,547
Restricted stock units	3,434,189	1,935,781	3,509,603	2,001,621
Performance units	2,251,254	2,282,211	2,196,073	2,027,985
Total	10,147,836	9,583,819	10,275,441	9,495,538